New pain cocktail could ease recovery after chest surgery
NCT ID NCT07424599
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding dexmedetomidine or dexamethasone to a standard numbing drug (bupivacaine) can provide longer pain relief after thoracoscopic thymectomy in people with myasthenia gravis. Sixty patients will be randomly assigned to one of three groups. The main goal is to see how long it takes before they need extra pain medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine with either dexmedetomidine or dexamethasone
- What this could lead to
- If it works, this could point toward a better way to manage pain after thymectomy, reducing the need for additional painkillers.
- What could go wrong
- This is a small, early-phase study with only 60 participants, so results may not apply to all patients. There is also a risk of side effects from the added medications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking daily life unlock myasthenia gravis mysteries?
- Can engineered immune cells tame a debilitating autoimmune disease?
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers
- Can DNA reveal the roots of a rare muscle disease?
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Deep breaths may slash post-surgery pain and anxiety — a trial puts it to the test